Unknown

Dataset Information

0

Lupeol synergizes with doxorubicin to induce anti-proliferative and apoptotic effects on breast cancer cells.


ABSTRACT:

Purpose

Anti-cancer and anti-migration effects of lupeol as a biological pentacyclic triterpenoid were investigated individually and in combination with Doxorubicin (DOX) on MCF-7 and MDA-MB-231 breast cancer cells and human foreskin fibroblasts.

Methods

To uncover the anticancer effect of lupeol and the impact of its combination with DOX, cell viability and scratch assays and dual acridine-orange apoptotic staining were performed. Moreover, the expression of proapoptotic caspase-3 and metastasis-related MMP-9 at the mRNA and protein levels was analyzed using qPCR and western blot techniques.

Results

Lupeol synergistically increased the anti-proliferative effect of DOX with IC50 values of 42.55, 62.24 and 65.9 μM on MCF-7, MDA-MB-231 and HFF cells, respectively. Lupeol reduced the cell migration and lowered the DOX-induced cell migration, significantly (p < 0.05). The number of apoptotic cells elevated significantly (p < 0.05) when cancer cells were treated with the combination of lupeol and DOX. Lupeol individually and in combination with DOX up-regulated the expression of caspase-3. The proposed combination therapy synergized (3-4 fold) the down-regulation of MMP-9 expression in MCF-7 and MDA-MB-231 cells.

Conclusion

Our results indicate that lupeol could be considered as an anticancer agent and anticancer adjuvant in breast cancer-therapy. The anticancer properties of lupeol attribute to its antiproliferative, antimigrative and apoptotic effects.

SUBMITTER: Malekinejad F 

PROVIDER: S-EPMC9114251 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lupeol synergizes with doxorubicin to induce anti-proliferative and apoptotic effects on breast cancer cells.

Malekinejad Faezeh F   Kheradmand Fatemeh F   Khadem-Ansari Mohammad Hassan MH   Malekinejad Hassan H  

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20220203 1


<h4>Purpose</h4>Anti-cancer and anti-migration effects of lupeol as a biological pentacyclic triterpenoid were investigated individually and in combination with Doxorubicin (DOX) on MCF-7 and MDA-MB-231 breast cancer cells and human foreskin fibroblasts.<h4>Methods</h4>To uncover the anticancer effect of lupeol and the impact of its combination with DOX, cell viability and scratch assays and dual acridine-orange apoptotic staining were performed. Moreover, the expression of proapoptotic caspase-  ...[more]

Similar Datasets

| S-EPMC2677148 | biostudies-other
| S-EPMC4400171 | biostudies-literature
| S-EPMC7527208 | biostudies-literature
| S-EPMC10967589 | biostudies-literature
| S-EPMC9338982 | biostudies-literature
| S-EPMC5438697 | biostudies-literature
| S-EPMC7442990 | biostudies-literature
| S-EPMC4075934 | biostudies-literature
| S-EPMC9604296 | biostudies-literature
| S-EPMC7584235 | biostudies-literature